NFKB1 and psoriasis: It has been shown that inhibition of p38 (Nadeem et al., 2017), JNK (Chamcheu et al., 2019), ERK (Chen et al., 2021) and NF-κB (Nadeem,Ahmad, 2017) signaling pathways can alleviate other chronic inflammatory skin diseases including psoriasis(Nadeem et al., 2015).